QR Code

Thrombopoietin participates in platelet activation in COVID-19 patients

Summary: Background: The pathogenesis of coronavirus disease 2019 (COVID-19) is characterized by enhanced platelet activation and diffuse hemostatic alterations, which may contribute to immunothrombosis/thromboinflammation and subsequent development of target-organ damage.Thrombopoietin (THPO), a g...

Whakaahuatanga katoa

I tiakina i:
Ngā kaituhi matua: Enrico Lupia, Marialessia Capuano, Barbara Vizio, Martina Schiavello, Ornella Bosco, Maria Gelardi, Edoardo Favale, Emanuele Pivetta, Fulvio Morello, Shahid Husain, Shaf Keshavjee, Lorenzo Del Sorbo, Giuseppe Montrucchio
Hōputu: Artigo
Reo:Inglês
I whakaputaina: Elsevier 2022-11-01
Rangatū:EBioMedicine
Ngā marau:
COVID-19
Thrombopoietin
Interleukin-6
Platelet activation
Biomarker
Thromboinflammation
Urunga tuihono:http://www.sciencedirect.com/science/article/pii/S235239642200487X
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite